2025-09-09 - Analysis Report
Okay, here's an analysis of Teladoc Health Inc. (TDOC) based on the provided information.  The report is structured to present the key data points first, followed by analysis and context.

## Teladoc Health Inc. (TDOC) Analysis

**Company Overview:** Teladoc Health Inc. is a telehealth company that provides virtual healthcare services.

**1. Performance vs. S&P 500 (VOO)**

*   **TDOC Cumulative Return:** -63.05%
*   **VOO Cumulative Return:** 97.02%
*   **Deviation:** -165.37 (TDOC significantly underperforming VOO)
*   **Relative Deviation:** 0.4 (Suggests current deviation is near the lower end of its historical range)

**Analysis of Alpha/Beta Table:**

The provided table shows the Alpha, Beta, and other factors of the stock, measured over different periods.

| Year       | CAGR    | MDD    | Alpha   | Beta  | Cap(B) |
|------------|---------|--------|---------|-------|--------|
| 2015-2017  | 76.0%   | 60.6%  | 52.0%   | 0.1   | 6.2    |
| 2016-2018  | 128.0%  | 59.3%  | 111.0%  | 0.0   | 8.8    |
| 2017-2019  | 176.0%  | 59.3%  | 149.0%  | 0.3   | 14.8   |
| 2018-2020  | 237.0%  | 64.0%  | 218.0%  | 0.1   | 35.4   |
| 2019-2021  | -83.0%  | 64.0%  | -130.0% | 0.0   | 16.3   |
| 2020-2022  | -295.0% | 81.3%  | -297.0% | 0.0   | 4.2    |
| 2021-2023  | -488.0% | 81.3%  | -506.0% | -0.5  | 3.8    |
| 2022-2024  | -111.0% | 81.3%  | -136.0% | -0.8  | 1.6    |
| 2023-2025  | -34.0%  | 75.5%  | -86.0%  | -0.8  | 1.4    |

*   **Analysis:**
    *   **CAGR:**  Historically, TDOC had impressive growth (CAGR) from 2015-2020. However, more recent periods (2019-2025) show significant negative growth.
    *   **MDD:**  Maximum Drawdown (MDD) is consistently high, indicating substantial volatility and potential for significant losses.
    *   **Alpha:**  Alpha is largely negative in recent periods, meaning TDOC has underperformed its benchmark (likely the S&P 500) after accounting for risk.
    *   **Beta:**  Beta is low or negative in recent periods. The negative betas indicates that the stock price has recently moved in the opposite direction of the benchmark.
    *   **Cap(B):** Market Capitalization (Cap) has decreased significantly, highlighting the decline in the company's valuation.

**2. Recent Stock Price Movements**

*   **Current Price:** 7.82
*   **Last Market Data:** Price: 7.84, Previous Close: 7.82, Change: 0.26
*   **5-Day Moving Average:** 7.725
*   **20-Day Moving Average:** 7.4763
*   **60-Day Moving Average:** 7.7071

**Analysis:** The stock price is slightly above its 5-day, 20-day, and 60-day moving averages. This could indicate a short-term upward trend. The last market data indicates a slight upward movement, suggesting positive momentum.

**3. Technical Indicators and Expected Return**

*   **Market Risk Indicator (MRI):** 0.33 (Low Risk)
*   **RSI:** 58.38 (Neutral - neither overbought nor oversold)
*   **PPO:** 0.6639
*   **Hybrid Signal:** cash_0%_Buy 80% of cash (1 shares - Caution - MRI:0.33)
*   **Recent (20-day) Relative Deviation Change:** 0.3 (+) (Short-term Increase)
*   **Expected Return (%):** -10253.5%

**Analysis:**

*   The Low Risk MRI suggests that the overall market conditions are not highly risky.
*   The RSI suggests a somewhat neutral to slightly bullish sentiment.
*   The Hybrid Signal suggests buying a small amount of shares, but with caution, given the recent underperformance and high volatility.
*   The *Delta_Previous_Relative_Divergence* indicates that the stock is seeing some short-term upward momentum relative to the S&P 500.
*   The Extremely Negative Expected Return implies that, based on current conditions, the model predicts significant underperformance compared to the S&P 500 over a longer-term investment horizon.

**4. Recent News & Significant Events:**

*   **Analyst Report (Argus Research):**  Coverage from Argus Research suggests continued interest and analysis of the stock.
*   **Market Digest (Argus Research):** Inclusion in a market digest indicates that TDOC is being actively monitored and compared to other companies.
*   **Motley Fool Article ("2 Beaten-Down Stocks to Avoid"):**  This is a negative signal, suggesting caution due to potential continued struggles.
*   **StockStory Article ("1 Cash-Producing Stock on Our Buy List and 2 We Find Risky"):**  Likely TDOC is one of the risky stocks.
*   **Zacks Article ("Why Is Teladoc (TDOC) Up 4.6% Since Last Earnings Report?"):**  This indicates a positive short-term reaction to earnings, but the analysis is needed to understand if the surge is sustainable.
*   **GlobeNewswire Report ("Telehealth and Telemedicine Company Evaluation Report 2025"):**  This suggests TDOC is a leader in the telehealth space, but the report needs to be analyzed to determine the company's competitive advantages and future growth prospects.

**4-2) Analyst Opinions**

*   **Consensus:** Hold (Mean: 2.64)
*   **Target Price:** Average: $9.12, High: $12.00, Low: $7.00

**Analysis:** The analyst consensus is "Hold," with an average target price of $9.12. This suggests analysts are neutral on the stock's potential, with a modest upside from the current price. The range of target prices ($7.00 - $12.00) indicates some uncertainty in the outlook.

**5. Recent Earnings Analysis**

| Date       | EPS   | Revenue    |
|------------|-------|------------|
| 2025-07-30 | -0.19 | 0.63 B$    |
| 2025-05-01 | -0.53 | 0.63 B$    |
| 2024-10-31 | -0.19 | 0.64 B$    |
| 2024-08-01 | -4.92 | 0.64 B$    |
| 2025-07-30 | -4.92 | 0.64 B$    |

*   **Analysis:**  The company is consistently generating revenue around $0.63-0.64 billion per quarter. EPS values are negative, indicating unprofitability. The earnings data reveals a struggle to translate revenue into profits. The large EPS losses in some quarters (e.g., -4.92) may be due to one-time charges or write-downs.

**6. Financial Information:**

**Revenue and Profitability:**

| Quarter    | Revenue | Profit Margin |
|------------|---------|---------------|
| 2025-06-30 | $0.63B  | 69.85%        |
| 2025-03-31 | $0.63B  | 68.73%        |
| 2024-12-31 | $0.64B  | 70.50%        |
| 2024-09-30 | $0.64B  | 71.94%        |
| 2024-06-30 | $0.64B  | 70.73%        |

**Capital and Profitability:**

| Quarter    | Equity  | ROE      |
|------------|---------|----------|
| 2025-06-30 | $1.42B  | -2.30%   |
| 2025-03-31 | $1.43B  | -6.52%   |
| 2024-12-31 | $1.49B  | -3.25%   |
| 2024-09-30 | $1.51B  | -2.21%   |
| 2024-06-30 | $1.50B  | -55.77%  |

**Analysis:**

*   **Revenue:** Revenue is relatively stable around $0.63-0.64B per quarter.
*   **Profit Margin:** Profit margins are high, consistently around 70%, suggesting strong pricing power in its core business, but this doesn't translate to overall profitability due to other expenses.
*   **Equity:** Equity has slightly decreased over the past few quarters.
*   **ROE:** Return on Equity (ROE) is negative, reflecting the company's unprofitability.  The large negative ROE in Q2 2024 suggests a particularly challenging quarter.

**7. Overall Summary and Analysis**

*   **Performance:** TDOC has significantly underperformed the S&P 500, with a substantial negative cumulative return and negative Alpha in recent years.
*   **Volatility:** The stock exhibits high volatility, as indicated by the high Maximum Drawdown figures.
*   **Recent Price Action:**  There's been a slight recent upward movement in the stock price.
*   **Technical Indicators:**  Technical indicators are mixed, with a "Hold" rating based on Hybrid Signal and negative expected return.
*   **News Sentiment:** News sentiment is mixed, with some positive articles regarding the telehealth market and TDOC's position, but also negative articles cautioning against investment.
*   **Analyst Consensus:** Analyst consensus is "Hold" with a modest potential upside.
*   **Financials:** Revenue is stable with high profit margins, but the company is currently unprofitable, as reflected by negative EPS and ROE.

**Conclusion:**

TDOC is a complex case. While it operates in a growing market (telehealth) and has high profit margins, it's currently unprofitable and has significantly underperformed the S&P 500. Recent news is mixed, and analyst opinions are neutral. The negative expected return and the warnings from some analysts suggest caution is warranted. The recent uptick in price and short-term relative deviation change are potentially positive signals, but need to be carefully monitored to determine if they represent a sustainable trend. Investors should carefully consider the risks and potential rewards before investing in TDOC.

